Literature DB >> 25052757

Helicobacter pylori virulence and cancer pathogenesis.

Yoshio Yamaoka1, David Y Graham.   

Abstract

Helicobacter pylori is human gastric pathogen that causes chronic and progressive gastric mucosal inflammation and is responsible for the gastric inflammation-associated diseases, gastric cancer and peptic ulcer disease. Specific outcomes reflect the interplay between host-, environmental- and bacterial-specific factors. Progress in understanding putative virulence factors in disease pathogenesis has been limited and many false leads have consumed scarce resources. Few in vitro-in vivo correlations or translational applications have proved clinically relevant. Reported virulence factor-related outcomes reflect differences in relative risk of disease rather than specificity for any specific outcome. Studies of individual virulence factor associations have provided conflicting results. Since virulence factors are linked, studies of groups of putative virulence factors are needed to provide clinically useful information. Here, the authors discuss the progress made in understanding the role of H. pylori virulence factors CagA, vacuolating cytotoxin, OipA and DupA in disease pathogenesis and provide suggestions for future studies.

Entities:  

Keywords:  CagA product; DupA; Helicobacter pylori; OipA; VacA; gastric cancer; genetic instability; inflammation-associated malignancy; next-generation sequencers; vacuolating cytotoxin; virulence factors

Mesh:

Substances:

Year:  2014        PMID: 25052757      PMCID: PMC4197059          DOI: 10.2217/fon.14.29

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  92 in total

1.  vacA i-region subtyping.

Authors:  Hiroaki Ogiwara; David Y Graham; Yoshio Yamaoka
Journal:  Gastroenterology       Date:  2008-02-08       Impact factor: 22.682

2.  Helicobacter pylori HopH (OipA) and bacterial pathogenicity: genetic and functional genomic analysis of hopH gene polymorphisms.

Authors:  Anar Dossumbekova; Christian Prinz; Jorg Mages; Roland Lang; Johannes G Kusters; Arnoud H M Van Vliet; Wolfgang Reindl; Steffen Backert; Dieter Saur; Roland M Schmid; Roland Rad
Journal:  J Infect Dis       Date:  2006-10-10       Impact factor: 5.226

3.  Helicobacter pylori-associated regulation of forkhead transcription factors FoxO1/3a in human gastric cells.

Authors:  Fazal H Tabassam; David Y Graham; Yoshio Yamaoka
Journal:  Helicobacter       Date:  2012-03-20       Impact factor: 5.753

4.  Helicobacter pylori activate epidermal growth factor receptor- and phosphatidylinositol 3-OH kinase-dependent Akt and glycogen synthase kinase 3beta phosphorylation.

Authors:  Fazal H Tabassam; David Y Graham; Yoshio Yamaoka
Journal:  Cell Microbiol       Date:  2008-09-08       Impact factor: 3.715

5.  Helicobacter pylori vacA arrangement and related diseases: a retrospective study over a period of 15 years.

Authors:  Vincenzo De Francesco; Marcella Margiotta; Angelo Zullo; Cesare Hassan; Floriana Giorgio; Mariangela Zotti; Giuseppe Stoppino; Alessia Bastianelli; Francesco Diterlizzi; Giovanna Verderosa; Sergio Morini; Carmine Panella; Enzo Ierardi
Journal:  Dig Dis Sci       Date:  2008-07-03       Impact factor: 3.199

6.  Molecular epidemiology and outcome of Helicobacter pylori infection in Thailand: a cultural cross roads.

Authors:  Ratha-Korn Vilaichone; Varocha Mahachai; Somying Tumwasorn; Jeng-Yih Wu; David Y Graham; Yoshio Yamaoka
Journal:  Helicobacter       Date:  2004-10       Impact factor: 5.753

7.  Role of deletion located between the intermediate and middle regions of the Helicobacter pylori vacA gene in cases of gastroduodenal diseases.

Authors:  Hiroaki Ogiwara; Mitsushige Sugimoto; Tomoyuki Ohno; Ratha-Korn Vilaichone; Varocha Mahachai; David Y Graham; Yoshio Yamaoka
Journal:  J Clin Microbiol       Date:  2009-09-02       Impact factor: 5.948

8.  Infection of less virulent Helicobacter pylori strains in asymptomatic healthy individuals in Thailand as a potential contributing factor to the Asian enigma.

Authors:  Itaru Hirai; Tadahiro Sasaki; Ai Kimoto; Yoshimasa Yamamoto; Takeshi Azuma; Varocha Mahachai; Piyathida Hansomburana; Comsun Lertkupinit; Somchai Luangjaru; Phadet Noophan; Rattikorn Chanatrirattanapan; Vanich Piyanirandr; Theeranan Sappajit; Karun Suthivarakom; Leelaowadee Sangsuk; Piyada Wangroongsarb
Journal:  Microbes Infect       Date:  2009-12-28       Impact factor: 2.700

9.  Helicobacter Pylori's plasticity zones are novel transposable elements.

Authors:  Dangeruta Kersulyte; Wookon Lee; Dharmalingam Subramaniam; Shrikant Anant; Phabiola Herrera; Lilia Cabrera; Jacqueline Balqui; Orsolya Barabas; Awdhesh Kalia; Robert H Gilman; Douglas E Berg
Journal:  PLoS One       Date:  2009-09-03       Impact factor: 3.240

10.  Genome sequence analysis of Helicobacter pylori strains associated with gastric ulceration and gastric cancer.

Authors:  Mark S McClain; Carrie L Shaffer; Dawn A Israel; Richard M Peek; Timothy L Cover
Journal:  BMC Genomics       Date:  2009-01-05       Impact factor: 3.969

View more
  53 in total

Review 1.  Pathogenesis of Helicobacter pylori Infection.

Authors:  Dionyssios N Sgouras; Tran Thi Huyen Trang; Yoshio Yamaoka
Journal:  Helicobacter       Date:  2015-09       Impact factor: 5.753

2.  Resistance to clarithromycin and gastroenterologist's persistence roles in nomination for Helicobacter pylori as high priority pathogen by World Health Organization.

Authors:  Amin Talebi Bezmin Abadi
Journal:  World J Gastroenterol       Date:  2017-09-21       Impact factor: 5.742

3.  New observations regarding Helicobacter pylori and gastric cancer in Mongolia.

Authors:  Boldbaatar Gantuya; Dashdorj Bolor; Khasag Oyuntsetseg; Yansan Erdene-Ochir; Ruvjir Sanduijav; Duger Davaadorj; Tegshee Tserentogtokh; Dashdorj Azzaya; Tomohisa Uchida; Takeshi Matsuhisa; Yoshio Yamaoka
Journal:  Helicobacter       Date:  2018-06-08       Impact factor: 5.753

4.  Changing the natural history of metachronous gastric cancer after H. pylori eradication.

Authors:  David Y Graham; Satoko Matsueda; Akiko Shiotani
Journal:  Jpn J Helicobacter Res       Date:  2015

5.  Helicobacter pylori vacA as marker for gastric cancer and gastroduodenal diseases: one but not the only factor.

Authors:  Amin Talebi Bezmin Abadi; Yeong Yeh Lee
Journal:  J Clin Microbiol       Date:  2014-12       Impact factor: 5.948

6.  Preferential Tim-3 expression on Treg and CD8(+) T cells, supported by tumor-associated macrophages, is associated with worse prognosis in gastric cancer.

Authors:  Pinying Shen; Rongxi Yue; Jiahong Tang; Haige Si; Liqun Shen; Changsheng Guo; Lixin Zhang; Huaizhong Han; Haihan K Song; Pengfei Zhao; Ning Wang; Zongchang Song; Chunliang Guo
Journal:  Am J Transl Res       Date:  2016-08-15       Impact factor: 4.060

Review 7.  Helicobacter pylori in gastric carcinogenesis.

Authors:  Hyo Jun Ahn; Dong Soo Lee
Journal:  World J Gastrointest Oncol       Date:  2015-12-15

8.  Expression analysis of apolipoprotein E and its associated genes in gastric cancer.

Authors:  Xiumin Shi; Jianting Xu; Jihan Wang; Meizi Cui; Yushun Gao; Haitao Niu; Haofan Jin
Journal:  Oncol Lett       Date:  2015-07-01       Impact factor: 2.967

Review 9.  Helicobacter pylori update: gastric cancer, reliable therapy, and possible benefits.

Authors:  David Y Graham
Journal:  Gastroenterology       Date:  2015-02-02       Impact factor: 22.682

10.  Prediction of Host-Pathogen Interactions for Helicobacter pylori by Interface Mimicry and Implications to Gastric Cancer.

Authors:  Emine Guven-Maiorov; Chung-Jung Tsai; Buyong Ma; Ruth Nussinov
Journal:  J Mol Biol       Date:  2017-10-26       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.